Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Maximilian Huttasch, Michael Roden, S. Kahl
Metabolism (2024) Vol. 157, pp. 155937-155937
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus
Xufen Zeng, Krista A Varady, Xiangdong Wang, et al.
Metabolism (2024) Vol. 161, pp. 156028-156028
Closed Access | Times Cited: 17
Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management
Daniel Simancas‐Racines, Giuseppe Annunziata, Ludovica Verde, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management
Stergios A. Pοlyzos, Christos S. Mantzoros
Metabolism (2024) Vol. 157, pp. 155936-155936
Closed Access | Times Cited: 9
Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis
Renuka Suvarna, Sahana Shetty, Joseph M. Pappachan
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999-2018
Weijie Liu, Xiulin Yang, Ting Zhan, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sara Jarmakiewicz-Czaja, Aneta Sokal, Rafał Filip
Medicina (2025) Vol. 61, Iss. 2, pp. 192-192
Open Access
Exercise-induced adipokine Nrg4 alleviates MASLD by disrupting hepatic cGAS-STING signaling
Min Chen, Yang Li, Jieying Zhu, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115251-115251
Open Access
The impact of sleeve gastrectomy on MASH development by regulating the composition of gut microbiota and metabolic homeostasis
Lingxi Ye, Zhenyu Yao, Qiuhui Xuan, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 752, pp. 151466-151466
Closed Access
Repeatability, reproducibility, and observer variability of body composition assessment with single-slice lumbar MRI
Magdalena Nowak, Luis Núñez, CJ Hill, et al.
Discover Imaging. (2025) Vol. 2, Iss. 1
Open Access
Mitochondrial targeted therapy in MAFLD
Sien Lai, Dongsheng Tang, Juan Feng
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151498-151498
Closed Access
Prevalence and association of metabolism-associated steatotic liver disease across age groups and gender
Salvatore Corrao, Salvatore Scibetta, Serena Scardina, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 103926-103926
Closed Access
Advanced lung cancer inflammation index: a key predictor of hepatic steatosis and fibrosis severity
Yajie Liu, Ruilin Wang
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Management of patients with the cardio renal liver metabolic syndrome: The need for a multidisciplinary approach in research, education and practice
Angeliki M. Angelidi, Despina Sanoudou, Michael A. Hill, et al.
Metabolism (2024) Vol. 159, pp. 155997-155997
Closed Access | Times Cited: 3
Molecular Pharmacology of Vitamin C and Relevance to Health and Obesity—A Narrative Review
Robert Wilson, Yicong Liang, Devesh Kaushal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7523-7523
Open Access | Times Cited: 2
GDF-15 improves the predictive capacity of Steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies
Michail Kokkorakis, Pytrik Folkertsma, José Castela Forte, et al.
Metabolism (2024), pp. 156047-156047
Closed Access | Times Cited: 2
Novel Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1435-1436
Open Access | Times Cited: 1
The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective
Chao Wang, Xin Huang, Shiming He, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
A new name for an old problem. Metabolic dysfunction-associated steatotic liver disease - review of literature
Adrian Kruszewski, Anna Dąbrowska, Paulina Przybysz, et al.
Quality in Sport (2024) Vol. 17, pp. 53023-53023
Open Access
Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
Michał Nicze, Adrianna Dec, Maciej Borówka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8202-8202
Open Access
Pyrazolopyridine and Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1806-1807
Open Access
Postbiotics as Antiinflammatory and Immune‐Modulating Bioactive Compounds in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Yusuf Yılmaz
Molecular Nutrition & Food Research (2024)
Open Access
Dysglycemia and liver lipid content influence the link between insulin resistance and liver mitochondrial function in obesity – Author’s reply
S. Kahl, Michael Roden
Journal of Hepatology (2024)
Closed Access
The effect of an isolated fat diet on the blood vessels of the rat´s brain (experimental randomized study)
Аssel B. Altynbekova, Elmira Mamytova, Yusuf Shidakov, et al.
Heart Vessels and Transplantation (2024), Iss. Ahead of Print
Open Access
Page 1 - Next Page

Scroll to top